Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 2Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 34Leukemia 18Myelodysplastic Syndromes 10Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Promyelocytic, Acute 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Congenital Abnormalities 5Anemia, Refractory, with Excess of Blasts 4Recurrence 3Leukemia, Myelomonocytic, Chronic 3Myeloproliferative Disorders 2Sarcoma, Myeloid 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Disease Progression 1Disease 1Blast Crisis 1

Interventions

Cytarabine 8Peripheral Blood Stem Cell Transplantation 3Idarubicin 3Filgrastim 2Daunorubicin 2Clofarabine 2tipifarnib 1temsirolimus 1sargramostim 1laromustine 1eltrombopag 1alvocidib 1aldesleukin 1Whole-Body Irradiation 1Radiotherapy 1Proto-Oncogene Proteins c-kit 1Polymerase Chain Reaction 1Mitoxantrone 1Melphalan 1Lenalidomide 1Injections 1Imatinib Mesylate 1Gene Expression Profiling 1Gemtuzumab 1Flow Cytometry 1Etoposide 1Decitabine 1Cyclosporine 1Cyclophosphamide 1Cilengitide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Basophilic, Acute × Gemtuzumab × Clear all
NCT00089050 2011-11-30

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡